Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Review of the Available Remedial Procedures for the Treatment of Fatty Liver Disease



Eskandari D1 ; Khodabandehloo N2 ; Samadanifard H1 ; Ziaee A3 ; Hejrati A4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of endocrinology, School of Medicine, Hazrat-e Rasool Hospital, Iran University of Medical Sciences, Tehran, Iran
  2. 2. School of Medicine, Hazrat-e Rasool Hospital, Iran University of Medical Sciences, Tehran, Iran
  3. 3. Institute of endocrinology and metabolism, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Internal Medicine, School of Medicine, Hazrat-e Rasool Hospital, Iran University of Medical Sciences, Tehran, Iran

Source: Pakistan Journal of Medical and Health Sciences Published:2020

Abstract

Fatty liver disease (FLD), known as a common cause of chronic liver disease globally, refers to a spectrum of disease-causing lipid accumulation in the liver. There are two types of FLD, including Alcoholic Liver Disease (ALD) and Non-Alcoholic Fatty Liver Disease (NAFLD). The pathological spectra of these two diseases are similar TO a range of conditions from steatosis to cirrhosis and hepatocellular carcinoma. The diagnosis of FLD relays highly on clinical suspicion, laboratory tests, or diagnostic techniques. Despite advancements in understanding the pathophysiology of FLD, targeted therapies for the disease are still absent. Abstinence, nutritional support, and medications such as corticosteroids and pentoxifylline are used for the management of patients with ALD. The treatment modality for patients with NAFLD is mainly based on weight loss and adjutant management using specific agents such as Insulin sensitizers and Anti-oxidants and cytoprotective therapies. The aim of this study is to provide a thorough review of the current therapies and strategies regarding the management of ALD and NAFLD. © 2020 Lahore Medical And Dental College. All rights reserved.
Related Docs
View other Related Docs
1. The Role of Moderate- and High-Intensity Supervised Aerobic Training in Reducing Steatosis and Hepatic Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease; a Randomized Controlled Trial, Gastroenterology and Hepatology from Bed to Bench (2023)
2. Unraveling the Link Between Insulin Resistance and Non-Alcoholic Fatty Liver Disease (Or Metabolic Dysfunction-Associated Steatotic Liver Disease): A Narrative Review, Journal of Diabetes and Metabolic Disorders (2023)
3. Effect of L-Carnitine Supplementation on Liver Enzymes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Archives of Medical Research (2020)
4. The Effects of Curcumin Supplementation on Body Mass Index, Body Weight, and Waist Circumference in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Dose–Response Meta-Analysis of Randomized Controlled Trials, Phytotherapy Research (2020)
5. Green Cardamom Supplementation Improves Serum Irisin, Glucose Indices, and Lipid Profiles in Overweight or Obese Non-Alcoholic Fatty Liver Disease Patients: A Double-Blind Randomized Placebo-Controlled Clinical Trial, BMC Complementary and Alternative Medicine (2019)
6. Efficacy of Nanocurcumin Supplementation on Insulin Resistance, Lipids, Inflammatory Factors and Nesfatin Among Obese Patients With Non-Alcoholic Fatty Liver Disease (Nafld): A Trial Protocol, BMJ Open (2017)
7. The Relationship Between Anthropometric Indices and Non-Alcoholic Fatty Liver Disease in Adults: A Cross-Sectional Study, Frontiers in Nutrition (2024)
8. Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis, Gastroenterology and Hepatology from Bed to Bench (2017)
Experts (# of related papers)
View all Related Experts
Kurosh Djafarian (2)
Reza Meshkani (2)
Other Related Docs
9. Dietary Inflammatory Potential and Metabolic (Dysfunction)-Associated Steatotic Liver Disease and Its Complications: A Comprehensive Review, Clinical Nutrition ESPEN (2025)
10. Effect of a Moderately Carbohydrate-Restricted Diet on Liver Enzymes, Steatosis and Fibrosis in Normal-Weight Individuals With Non-Alcoholic Fatty Liver Disease: Study Protocol for a Parallel Randomised Controlled Clinical Trial, BMJ Open (2023)
11. Combination of Metformin and Genistein Alleviates Non-Alcoholic Fatty Liver Disease in High-Fat Diet-Fed Mice, Journal of Nutritional Biochemistry (2021)
12. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease, Advances in Nutrition (2021)
13. Hesperidin Improves Hepatic Steatosis, Hepatic Enzymes, and Metabolic and Inflammatory Parameters in Patients With Nonalcoholic Fatty Liver Disease: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial, Phytotherapy Research (2019)
14. Lean Individual's Non-Alcoholic Fatty Liver Disease: A Review Article; [بیماري کبد چرب غیرالکلی در افراد لاغر: یک مقاله مروري], Tehran University Medical Journal (2022)
15. A Crosstalk Between Epigenetic Modulations and Non-Alcoholic Fatty Liver Disease Progression, Pathology Research and Practice (2023)
16. The Effect of Daily Consumption of Probiotic Yogurt on Liver Enzymes, Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease (Nafld): Study Protocol for a Randomized Clinical Trial, BMC Gastroenterology (2022)
17. Microrna-141 Is Associated With Hepatic Steatosis by Downregulating the Sirtuin1/Amp-Activated Protein Kinase Pathway in Hepatocytes, Journal of Cellular Physiology (2020)
18. Green Cardamom Increases Sirtuin-1 and Reduces Inflammation in Overweight or Obese Patients With Non-Alcoholic Fatty Liver Disease: A Double-Blind Randomized Placebo-Controlled Clinical Trial, Nutrition and Metabolism (2018)
19. Advancing the Global Public Health Agenda for Nafld: A Consensus Statement, Nature Reviews Gastroenterology and Hepatology (2022)
20. Curcumin Can Be Acts As Effective Agent for Prevent or Treatment of Alcohol-Induced Toxicity in Hepatocytes: An Illustrated Mechanistic Review, Iranian Journal of Pharmaceutical Research (2021)
21. A Randomized Triple-Blind Controlled Clinical Trial Evaluation of Sitagliptin in the Treatment of Patients With Non-Alcoholic Fatty Liver Diseases Without Diabetes, Frontiers in Medicine (2022)
22. Prevalence of Diabetic Neuropathy in Nonalcoholic Fatty Liver Disease (Nafld) Patients: A Systematic Review and Meta-Analysis, Neurology Asia (2024)
23. Dietary Supplements and Pediatric Non-Alcoholic Fatty Liver Disease: Present and the Future, World Journal of Hepatology (2015)
24. Associations Between Ultra-Processed Foods and Risk of Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Cross-Sectional Study, Iranian Journal of Nutrition Sciences and Food Technology (2025)
25. The Effects of Gut Microbiome Manipulation on Glycemic Indices in Patients With Non-Alcoholic Fatty Liver Disease: A Comprehensive Umbrella Review, Nutrition and Diabetes (2024)
26. The Association Between Nonalcoholic Fatty Liver Disease and Corrected Qt Interval Prolongation Among Generally Healthy Iranian Population: Fasa Cohort Study (Facs), Clinical Cardiology (2023)
27. Emerging Role of Nanotechnology in Treatment of Non-Alcoholic Fatty Liver Disease (Nafld), EXCLI Journal (2023)